Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-11-121327
Filing Date
2011-05-02
Accepted
2011-05-02 15:24:21
Documents
4
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 244080
2 CERTIFICATION OF CEO PURSUANT TO RULES 13A-15(E) dex311.htm EX-31.1 9070
3 CERTIFICATION OF CFO PURSUANT TO RULES 13A-15(E) dex312.htm EX-31.2 9070
4 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 5830
  Complete submission text file 0001193125-11-121327.txt   269164
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33221 | Film No.: 11800222
SIC: 2834 Pharmaceutical Preparations